Combination Therapy With Intravitreal Nesvacumab+Aflibercept in Diabetic Macular Edema: The Phase 2 RUBY Trial

Related

• 

  Foveal Capillary Perfusion Density Decreases in Diabetics with DME Treated on a Fixed Regimen of Intravitreal Aflibercept Injections Over 24 Months

  Brittney Statler, MD

  Updates from the Field

  2020

• 

  Expert Panel: Socioeconomics

  Linda A. Lam, MD, MBA, FASRS

  Ella H Leung, MD

  Mohsin H. Ali, MD

  Hasenin Al-khersan, MD

  Miguel A. Busquets, MD, FACS

  Annual Meeting Talks

  2024

• 

  Vitrectomy and Secondary IOL Fixation Techniques in Patients With Dropped Lens Nucleus and Dislocated IOLS: A Video-Based Course

  Berna Ozkan, MD

  On Demand Cases, Courses, and Papers

  2018